Autoantibodies in hospitalised patients with COVID‐19

Abstract Objectives CD209L and its homologous protein CD209 act as alternative entry receptors for the SARS‐CoV‐2 virus and are highly expressed in the virally targeted tissues. We tested for the presence and clinical features of autoantibodies targeting these receptors and compared these with autoa...

Full description

Bibliographic Details
Published in:Clinical & Translational Immunology
Main Authors: Eleni Tiniakou, Livia Casciola‐Rosen, Mekha A Thomas, Yuka Manabe, Annukka AR Antar, Mahendra Damarla, Paul M Hassoun, Li Gao, Zitong Wang, Scott Zeger, Antony Rosen
Format: Article
Language:English
Published: Wiley 2024-01-01
Subjects:
anti‐ACE2 IgM
anti‐CD209 IgM
anti‐CD209L IgM
autoantibodies
COVID‐19
Online Access:https://doi.org/10.1002/cti2.70019

Internet

https://doi.org/10.1002/cti2.70019

Similar Items